Acumen Pharmaceuticals's market cap is currently $87.12M. The company's EPS TTM is $-1.37; its P/E ratio is ―; Acumen Pharmaceuticals is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 1.44M	$ 1.70M
Gross Profit	$ -42.32M	$ -169.00K	$ -4.00K	$ 1.43M	$ 1.69M
Operating Income	$ -61.14M	$ -45.24M	$ 61.57M	$ -7.91M	$ -7.80M
EBITDA	$ -51.61M	$ -42.69M	$ 61.58M	$ 587.00K	$ 119.00K
Net Income	$ -52.37M	$ -40.48M	$ -181.68M	$ -7.32M	$ -7.86M
Balance Sheet
Cash & Short-Term Investments	$ 243.52M	$ 177.60M	$ 194.24M	$ 43.78M	$ 6.55M
Total Assets	$ 310.13M	$ 196.59M	$ 230.33M	$ 44.43M	$ 7.32M
Total Debt	$ 28.49M	$ 105.00K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -38.40M	$ -130.00M	$ -122.16M	$ -43.78M	$ -6.55M
Total Liabilities	$ 43.15M	$ 7.81M	$ 5.15M	$ 63.02M	$ 18.74M
Stockholders' Equity	$ 266.97M	$ 188.78M	$ 225.18M	$ -18.59M	$ -11.42M
Cash Flow
Free Cash Flow	$ -43.09M	$ -35.31M	$ -18.00M	$ -7.45M	$ -6.82M
Operating Cash Flow	$ -43.06M	$ -35.15M	$ -17.96M	$ -7.45M	$ -6.82M
Investing Cash Flow	$ -171.67M	$ 39.19M	$ -104.12M	$ 0.00	$ 0.00
Financing Cash Flow	$ 151.75M	$ 3.91M	$ 200.47M	$ 44.67M	$ 6.24M

Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

Income Statement >

Acumen Pharmaceuticals Debt to Assets

Balance Sheet >

Acumen Pharmaceuticals Cash Flow

Cash Flow >

Acumen Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing